spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

First published online October 11, 2005
doi: 10.1242/10.1242/jcs.02594


Journal of Cell Science 118, 4901-4912 (2005)
Published by The Company of Biologists 2005
This Article
Right arrow Summary Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vogelmann, R.
Right arrow Articles by Menke, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vogelmann, R.
Right arrow Articles by Menke, A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

TGFß-induced downregulation of E-cadherin-based cell-cell adhesion depends on PI3-kinase and PTEN

Roger Vogelmann1,*, Marc-Daniel Nguyen-tat1, Klaudia Giehl2, Guido Adler1, Doris Wedlich3 and Andre Menke1,{ddagger}

1 Department of Internal Medicine I, University of Ulm, Robert-Koch-Strasse 8, 89070 Ulm, Germany
2 Department of Pharmacology and Toxicology, University of Ulm, Robert-Koch-Strasse 8, 89070 Ulm, Germany
3 Institute of Zoology II, University of Karlsruhe, 76131 Karlsruhe, Germany



View larger version (92K):

[in a new window]
 
Fig. 1. PANC-1 and BxPC-3 cells were serum-starved for 24 hours and treated with solvent (–TGFß) or 10 ng/ml TGFß1 (+TGFß1) for 2 days. (A) The left panel shows phase contrast pictures. (B) The right panel shows immunofluorescence staining of E-cadherin. Bars, 20 µm. (C) Western blot analyses of E-cadherin, {alpha}- and ß-catenin in total lysates of PANC-1 and BxPC-3 cells treated with 10 ng/ml TGFß1 for the indicated periods of time. Equal loading was demonstrated by staining of ß-actin. Molecular mass standards are given in Mr x103. Representative blots out of four independent experiments are shown.

 


View larger version (20K):

[in a new window]
 
Fig. 2. (A) Cell aggregation assays were performed by incubation of pancreatic carcinoma cells PANC-1 and BxPC-3 under constant agitation in HEPES buffer plus CaCl2 supplemented with solvent, TGFß1 (10 ng/ml), EDTA/EGTA (5 mM each) or TGFß1 (10 ng/ml) + E-cadherin neutralising antibody (nAB=DECMA1, 4 µg/ml). The aggregation index was determined by A=(No–Ne)/No, No represents the total particle number before and Ne the particle number after 30 minutes of incubation with constant rotation at 70 rpm. Mean values ±s.e.m. are shown of three independent experiments. (B) Cell migration of PANC-1 and BxPC-3 was analysed using uncoated or collagen type I-coated transwell cell culture inserts with 8 µm pores. After inhibition of cell proliferation by treatment with 10 µg/ml mitomycin C, 20 ng/ml TGFß1 or solvent were added to the lower compartment. After 48 hours of incubation the number of cells, which had migrated through the pores, was estimated by counting 5 independent visual fields. Three independent assays were performed in triplicate. Mean values ±s.e.m. are shown.

 


View larger version (31K):

[in a new window]
 
Fig. 3. Triton-soluble and -insoluble protein fractions were analysed regarding their amounts of E-cadherin, {alpha}- and ß-catenin in PANC-1 and BxPC-3 cells after treatment with TGFß1 (10 ng/ml) or solvent for the time points indicated (A). Equal amounts of each fraction were separated by SDS-PAGE and blotted onto nitrocellulose. E-cadherin, {alpha}- and ß-catenin were detected by immunostaining. The ß-actin concentration served as control to prove equal loading. Representative blots out of four independent experiments are shown. (B) E-cadherin was precipitated from lysate of TGFß1-stimulated or unstimulated PANC-1 cells and coprecipitated {alpha}- and ß-catenin was analysed by western blotting. After serum starvation for 24 hours, cells were incubated for 90 minutes either with 100 µM PP1 to inhibit Src-kinase, 25 µM PD98059 to inhibit MEK-1 or with 25 µM LY294002 to inhibit PI3-kinase and stimulated with 10 ng/ml TGFß1 or solvent for additional 6 hours. E-cadherin was precipitated from 1 mg of NOP lysate. The amount of co-immunoprecipitated {alpha}- and ß-catenin was examined by immunoblotting. The blots were restained for E-cadherin to document equal amounts of precipitated protein. Three independent experiments were performed.

 


View larger version (37K):

[in a new window]
 
Fig. 4. (A) Transwell migration assays were performed as described before. The inhibitors LY294002 (25 µM) or PD98059 (25 µM) were added to the upper compartment. TGFß1 (20 ng/ml) or solvent was added to the lower chamber. The number of migrated cells was estimated after 48 hours of incubation. Mean values ±s.d. of one representative assay are shown out of three independent experiments. (B) The amount of PI3-kinase associated with the E-cadherin complex was analysed by co-immunoprecipitation. Beta catenin was precipitated from lysates of PANC-1 or BxPC-3 cells treated for 30 minutes, 6 hours or 48 hours with TGFß1. The amount of co-precipitated p85{alpha} was analysed by western blotting. (C) The amount of p110{alpha} co-precipitated with ß-catenin was analysed in PANC-1 or BxPC-3 lysates. Beta-catenin was precipitated from 2 mg of PANC-1 or 1 mg of BxPC-3 NOP lysate treated with 10 ng/ml TGFß1 or solvent. One representative blot out of three is shown. (D) Immunolocalisation of p85{alpha} was performed in PANC-1 cells treated with 10 ng/ml TGFß1 or solvent (–TGFß1) for 3 hours. P85{alpha} localisation was analysed with confocal laser microscopy. Bar, 20 µm.

 


View larger version (38K):

[in a new window]
 
Fig. 5. (A) Phosphorylation of {alpha}- and ß-catenin after TGFß1 treatment (10 ng/ml) for 30 minutes, 6 hours and 48 hours for BxPC-3 and additionally after 12 hours for PANC-1 cells was determined by immunoprecipitation of the individual proteins from isolated membrane fractions. Phosphorylated tyrosine was detected using a phosphotyrosine-specific antibody. Blots were restained with antibodies used for immunoprecipitation to document equal amounts of precipitated proteins. Representative blots out of three independent experiments are shown. (B) Phosphorylation of ß-catenin or (C) {alpha}-catenin was examined after treatment of PANC-1 cells with TGFß1, the PI3-kinase inhibitor LY294002 or the Src inhibitor PP1 (only for ß-catenin phosphorylation). Beta-catenin or {alpha}-catenin was precipitated from 1 mg of PANC-1 RIPA-lysates treated with TGFß1, TGFß1 plus PP1 or TGFß1 plus LY294002. Blots were restained for ß- or {alpha}-catenin to document equal amounts of precipitated protein. (D) TGFß1-induced ß-catenin phosphorylation was analysed in the presence of the farnesyltransferase inhibitor FTI 277 (2 µM) to inhibit Ras activity. In addition PANC-1 cells, which stably expressed EGFP/H-Ras N17, were analysed for ß-catenin phosphorylation in response to 10 ng/ml TGFß1 or solvent. Beta-catenin immunoprecipitated from 1 mg of PANC-1 RIPA lysate was analysed regarding its phosphorylation by western blotting with a phospho-specific antibody. Equal amounts of ß-catenin were documented by restaining the blots with ß-catenin antibody. Representative blots are shown (n=3). (E) In addition to the pictures shown in Fig. 4D, immunolocalisation of p85{alpha} was performed in PANC-1 cells stably expressing EGFP/H-Ras N17 treated with TGFß1 or solvent (–TGFß1) for 3 hours and analysed with confocal laser microscopy. Bar, 20 µm.

 


View larger version (46K):

[in a new window]
 
Fig. 6. (A) Immunoprecipitation of E-cadherin, {alpha}- or ß-catenin was performed from 500 µg of PANC-1 RIPA lysate and PTEN was detected by immunoblotting. Equal amounts of immunoprecipitated proteins were documented by restaining the blots with the appropriated antibody. (B) Beta-catenin was precipitated from 2 mg of BxPC-3 or PANC-1 lysates treated with 10 ng/ml TGFß1 or solvent. Co-precipitated PTEN was detected by western blotting. The blots were restained with anti-ß-catenin antibody to demonstrate equal amounts of protein. (C) E-cadherin was precipitated from 0.5 mg of total lysate from PANC-1 cells transiently transfected with PTEN, PTEN{Delta}C or vector alone (mock). Co-precipitated {alpha}- and ß-catenin was determined by western blotting. Restaining of the blot for E-cadherin confirmed equal amounts of precipitated proteins. In all experiments representative blots out of three independent studies are shown.

 


View larger version (43K):

[in a new window]
 
Fig. 7. (A) Beta-catenin was immunoprecipitated from 1 mg of PANC-1 lysate of cells transfected with pEGFP, pEGFP-PTEN or pEGFP-PTEN{Delta}C, treated with 10 ng/ml TGFß1 or solvent for 6 hours and analysed for its tyrosine phosphorylation. The blot was restained for ß-catenin to demonstrate equal amounts of protein. (B) For an in vitro phosphatase assay, tyrosine phosphorylated ß-catenin was incubated for 30 minutes at 30°C with EGFP-PTEN-constructs, which were immunoprecipitated with anti-EGFP antibody. The amount of phosphorylated ß-catenin was analysed by western blotting. Restaining of the blots with anti-ß-catenin antibody revealed equal amounts of phosphatase substrate and restaining with anti-PTEN documents the presence of both EGFP-tagged PTEN proteins. Representative assays out of four independent experiments are shown. (C) Beta-catenin was immunoprecipitated from 1 mg of lysate from PANC-1 cells transfected with siRNA for PTEN and treated with TGFß1 (10 ng/ml) or solvent (two independent experiments each) or an unrelated control siRNA and analysed for its tyrosine phosphorylation. Restaining for ß-catenin is shown to document equal loading. PTEN protein expression was analysed by western blots stained for PTEN. Representative assays are shown (n=3). (D) Phosphorylation of Ser380 of PTEN, which was co-immunoprecipitated with ß-catenin, was analysed after TGFß1 treatment. Beta-catenin was immunoprecipitated from 2 mg of PANC-1 lysate treated with TGFß1 for 30 minutes or 6 hours. In addition PANC-1 cells were examined, which were pretreated with the farnesyltransferase inhibitor FTI 277 (2 µM) for 2 hours prior to addition of TGFß1 for 6 hours. Co-precipitated PTEN was analysed regarding the phosphorylation at Ser380 with a phospho-specific antibody. Restaining for ß-catenin documented equal amounts of precipitated protein. A representative blot out of three independent experiments is shown.

 

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




© The Company of Biologists Ltd 2005